Effects of intravitreal bevacizumab (Avastin) therapy on retrobulbar blood flow parameters in patients with neovascular age-related macular degeneration. [electronic resource]
Producer: 20100406Description: 66-70 p. digitalISSN:- 1097-0096
- Aged
- Aged, 80 and over
- Angiogenesis Inhibitors -- administration & dosage
- Antibodies, Monoclonal -- administration & dosage
- Antibodies, Monoclonal, Humanized
- Bevacizumab
- Blood Flow Velocity -- drug effects
- Female
- Follow-Up Studies
- Humans
- Injections
- Macular Degeneration -- complications
- Male
- Middle Aged
- Ophthalmic Artery -- diagnostic imaging
- Prospective Studies
- Regional Blood Flow -- drug effects
- Retinal Artery -- diagnostic imaging
- Retinal Neovascularization -- diagnosis
- Retinal Vein -- diagnostic imaging
- Treatment Outcome
- Ultrasonography, Doppler, Color -- methods
- Vascular Endothelial Growth Factor A -- antagonists & inhibitors
- Vitreous Body
No physical items for this record
Publication Type: Comparative Study; Journal Article
There are no comments on this title.
Log in to your account to post a comment.